Ozempic is not inherently bad for you, but it carries real risks that range from common nuisances to rare serious complications. For most people using it as prescribed for type 2 diabetes or weight management, the benefits tend to outweigh the downsides. The picture changes depending on your medical history, how you source the drug, and whether you’re monitoring for warning signs.
The Side Effects Most People Experience
Gastrointestinal problems are by far the most common issue. Nausea, vomiting, diarrhea, and abdominal pain affect a significant portion of users, especially in the first weeks and whenever the dose increases. These symptoms usually improve as your body adjusts, and starting at a low dose with gradual increases helps minimize them. For some people, though, the nausea never fully resolves and becomes a reason to stop treatment.
These gut symptoms aren’t just uncomfortable. They can lead to dehydration, which is the mechanism behind a more serious concern: kidney problems. Post-marketing reports have documented cases of acute kidney injury in people taking Ozempic and similar drugs, sometimes in patients with no prior kidney disease. The common thread in most of those cases was persistent vomiting or diarrhea causing dehydration. Staying well-hydrated matters more on this medication than you might expect.
The FDA’s Most Serious Warning
Ozempic carries the FDA’s strongest safety label, a black box warning, for thyroid tumor risk. In animal studies, semaglutide (the active ingredient) caused thyroid C-cell tumors at doses comparable to what humans take. Whether this translates to humans remains unknown. The warning exists because the possibility hasn’t been ruled out.
This makes Ozempic off-limits for anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. If you notice a lump in your neck, difficulty swallowing, or persistent hoarseness while taking Ozempic, those are symptoms worth getting checked promptly.
Pancreatitis and Gallbladder Problems
Acute pancreatitis, an inflammation of the pancreas that causes severe abdominal pain, is a known risk with this class of drugs. The UK’s medicines regulator received 1,296 reports of pancreatitis tied to GLP-1 drugs between 2007 and October 2025, including 19 deaths. Patient information for similar drugs notes that acute pancreatitis may affect up to 1 in 100 users. The risk is low in absolute terms, but pancreatitis can be life-threatening when it occurs.
Gallbladder disease is another concern. In clinical trials, gallstones developed in 1.5% of patients on the lower dose of Ozempic compared to none in the placebo group. Rapid weight loss from any cause increases gallstone risk, so this isn’t unique to the medication, but it’s worth being aware of. Sudden, intense pain in your upper right abdomen, especially after eating, could signal a gallbladder issue.
Muscle Loss During Weight Loss
One of the more nuanced concerns is what happens to your body composition. When you lose weight on Ozempic, you lose both fat and muscle. This is true of any significant weight loss, not just medication-assisted loss. Research on semaglutide shows that while lean mass does decrease in absolute terms, the ratio of lean mass to total body weight actually improves, meaning you’re losing proportionally more fat than muscle. Still, larger clinical trials have found meaningful reductions in lean mass, which matters especially for older adults who can’t afford to lose muscle.
Resistance training during treatment is the most effective way to preserve muscle. If you’re on Ozempic and not doing any strength exercise, you’re more vulnerable to the weakness and metabolic slowdown that come with losing lean tissue.
The Proven Benefits
The risk conversation only makes sense alongside the benefit conversation. For people with type 2 diabetes, Ozempic reduces A1C levels by 1 to 1.5 percentage points, which is considered a strong effect. The 2026 American Diabetes Association guidelines now recommend drugs in this class not just for blood sugar control but specifically for their cardiovascular and kidney benefits. Semaglutide has shown protection against atherosclerotic cardiovascular disease and slows the progression of chronic kidney disease. Current guidelines prioritize it for patients with heart disease, kidney disease, or obesity alongside diabetes.
There’s also emerging evidence of benefit for fatty liver disease. These aren’t minor perks. For someone with type 2 diabetes and existing heart or kidney problems, the protective effects of Ozempic may significantly outweigh the risks of the side effects listed above.
Who Should Not Take It
Certain people should avoid Ozempic entirely. Beyond the thyroid cancer history mentioned above, it should not be used by people with type 1 diabetes or diabetic ketoacidosis, conditions that require insulin. People with severe gastroparesis, where the stomach empties abnormally slowly, should also avoid it since the drug further slows gastric emptying.
The Danger of Compounded Versions
One of the biggest real-world risks doesn’t come from the drug itself but from where people get it. The FDA has received reports of serious adverse events, some requiring hospitalization, from compounded semaglutide products. These are versions mixed by compounding pharmacies rather than manufactured by the original drugmaker, and they don’t undergo FDA review for safety or quality.
The most alarming pattern involves dosing errors. Patients have accidentally injected 5 to 20 times the intended dose when drawing from multi-dose vials. Healthcare providers have also miscalculated doses when converting between milligrams and units. The resulting overdoses caused severe nausea, vomiting, acute pancreatitis, gallstones, fainting, and dehydration.
Some compounders also use different chemical forms of semaglutide, such as semaglutide sodium or semaglutide acetate, which are not the same active ingredient found in FDA-approved Ozempic. Others add ingredients like vitamin B-12, L-carnitine, or NAD whose safety in combination with semaglutide has never been tested. If you’re getting semaglutide from any source other than the brand-name manufacturer through a licensed pharmacy, the risk profile is significantly worse and largely unknown.